Science Explorer Back to mapMap
Discussion
Researcher · Arizona Oncology · United States

Christopher Di Simone

Christopher Di Simone publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment and Renal and related cancers.

OpenAlex
World rank
#2,490,928
of 7,710,434 ranked researchers
Rank in United States
#734,921
of 1,627,098
Works
19
Citations
1k
Citations per work
53.9
h-index
9
i10-index 9Top 65% in Oncology
Christopher Di Simone

What does Christopher Di Simone research?

Christopher Di Simone's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 10 works · 53.0% of their workMedicine: 10 works · 53.0% of their workOncology: 4 works · 21.6% of their workPulmonary and Respiratory Medicine: 3 works · 15.7% of their workEpidemiology: 2 works · 9.8% of their workGenetics: 1 works · 5.9% of their workEverything else: 6 works · 31.3% of their workLife Sciences: 3 works · 15.7% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 15.7% of their workMolecular Biology: 2 works · 9.8% of their workGenetics: 1 works · 5.9% of their workTHEIR WORKChristopher DiSimone19works
Life Sciences16%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1053.0%
  2. Everything else631.3%
    1. Biochemistry, Genetics and Molecular Biology315.7%
  1. 1Oncology22% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Molecular Biology10% of their works
  4. 4Epidemiology10% of their works
  5. 5Genetics6% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Christopher Di Simone's research?

The keywords of their largest research topics: Prognostic Factors, Immune Checkpoint Blockade, Metastatic, PD-1 and PD-L1, Renal Cell Carcinoma, Rituximab, Kidney Organoids and Nephrogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Prognostic Factors92 topics
  2. Immune Checkpoint Blockade61 topic
  3. Metastatic61 topic
  4. PD-1 and PD-L161 topic
  5. Renal Cell Carcinoma61 topic
  6. Rituximab62 topics
  7. Kidney Organoids41 topic
  8. Nephrogenesis41 topic
  9. Chronic Lymphocytic Leukemia31 topic
  10. Classification31 topic
  11. Gene Therapy31 topic
  12. Genomic Aberrations31 topic
  13. Lymphoma31 topic
  14. Viral Vectors31 topic
  15. Cancer Genomics21 topic
  16. Cytomegalovirus21 topic
  17. Infection21 topic
  18. Mutational Signatures21 topic

Where does Christopher Di Simone work?

Christopher Di Simone's main affiliation in the publication record is Arizona Oncology, United States.

How many publications and citations does Christopher Di Simone have?

OpenAlex counts 19 works and 1,025 citations for Christopher Di Simone, an h-index of 9, ranking #2,490,928 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christopher Di Simone. Posts are plain text and can be reported.